Base-Selective Cleavage of Dinucleoside Monophosphates
A R T I C L E S
to room temperature, and sodium borohydride (0.10 mol, 3.8 g) was
slowly added. Stirring was continued for 48 h at room temperature,
and the formation of 11 was checked by LC/ESI-MS (m/z 288 [M +
H]+ and 310 [M + Na]+). The solvent was removed under reduced
pressure. Water (100 mL) was added to the residue, and the aqueous
phase was extracted with DCM (5 × 50 mL). The combined DCM
extracts were dried with Na2SO4 and evaporated to dryness under
reduced pressure. The crude product was used for the next step without
purification.
4H), 4.60 (s, 4H), 3.86 (m, 2H), 3.38 (m, 24H), 2.01 (m, 4H), 1.76 (m,
4H), 1.46 (s, 36H), 1.44 (s, 18H). 13C NMR (CDCl3, 50 °C): δ 156.20,
155.94, 138.67, 128.28, 126.78, 126.55, 79.77, 79.53, 75.68, 71.78,
49.70, 46.89, 44.98, 29.40, 28.40. HR-MS for (MH - C5H8O2)+,
C56H96N6O14: requires 977.6538, found 977.6503.
Hexa-tert-butyl 3,3′-[1,4-Phenylenebis(methylene)bis(oxy)]bis-
(1,5,9-triazacyclododecane-1,5,9-tricarboxylate) (16). 1,4-Bis(bro-
momethyl)benzene (0.72 mmol, 0.19 g) was used. Compound 16 was
1
obtained in 85% yield (0.66 g). H NMR (CDCl3, 50 °C): δ 7.28 (s,
4H), 4.61 (s, 4H), 3.88 (m, 2H), 3.41 (m, 24H), 2.04 (m, 4H), 1.79 (m,
4H), 1.48 (s, 36H), 1.47 (s, 18H). 13C NMR (CDCl3, 50 °C): δ 156.25,
155.97, 137.93, 127.49, 79.82, 79.59, 75.67, 71.72, 49.69, 47.00, 45.01,
29.45, 28.43, 28.42. HR-MS for (MH - C5H8O2)+, C56H96N6O14:
requires 977.6538, found 977.6520.
1,5,9-Triazacyclododecan-3-ol (12). The crude product of 11 was
heated for 4 d in 4 mol L-1 aqueous HCl (600 mL) under reflux and
evaporated to dryness under reduced pressure. Addition of MeOH (80
mL) to the residue gave 12 as a pure trihydrochloride in 93% yield
1
(5.63 g) (calculated by comparison to 10). H NMR (D2O): δ 4.25
(quint., J ) 5.3 Hz, 1H), 3.37 (m, 12H), 2.16-2.11 (quint., J )
6.6 Hz, 4H). 13C NMR (D2O): δ 61.65, 47.93, 43.20, 41.00, 19.24.
HR-MS for C9H21N3O: requires 187.1685, found 187.1683.
Hexa-tert-butyl 3,3′-[Biphenyl-4,4′-diylbis(methylene)bis(oxy)]bis-
(1,5,9-triazacyclododecane-1,5,9-tricarboxylate) (17). 4,4′-Bis(chlo-
romethyl)biphenyl (0.72 mmol, 0.18 g) was used. Compound 17 was
obtained in 82% yield (0.68 g). 1H NMR (CDCl3): δ 7.51 (d, J ) 8.1
Hz, 4H), 7.37 (d, J ) 8.1 Hz, 4H), 4.64 (s, 4H), 3.87 (quint., J ) 5.9
Hz, 2H), 3.60 (dd, J ) 5.9, 14.9 Hz, 4H), 3.40 (m, 12H), 3.16 (m,
8H), 2.01 (m, 4H), 1.74 (m, 4H), 1.46 (s, 36H), 1.42 (s, 18H). 13C
NMR (CDCl3): δ 156.29, 156.01, 140.28, 137.50, 128.11, 127.01,
79.91, 79.66, 75.30, 71.55, 49.50, 47.05, 44.93, 29.46, 28.43. HR-MS
for (MH - C5H8O2)+, C62H100N6O14: requires 1053.6851, found
1053.6873.
Tri-tert-butyl 3-Hydroxy-1,5,9-triazacyclododecane-1,5,9-tricar-
boxylate (13). 1,5,9-Triazacyclododecan-3-ol trihydrochloride (19.0
mmol, 5.63 g) was dissolved in a mixture of tert-butyl alcohol (120
mL) and aqueous sodium hydroxide (80 mL of 2.9 mol L-1 solution).
Di-tert-butyl dicarbonate (Boc2O, 62.8 mmol, 13.7 g) in tert-butyl
alcohol (50 mL) was added to this solution with vigorous stirring. The
stirring was continued at room temperature overnight and then at
40-50 °C for 2 d. Formation of 13 was followed by LC/ESI-MS (m/z
488 [M + H]+, 510 [M + Na]+). Because the reactivity of the hydroxyl
group turned out to be only moderately lower than that of the ring
nitrogen atoms, Boc2O could not be used in excess, and still ester
formation could not be entirely avoided. The 2 days of incubation at
40-50 °C, however, resulted in isomerization to the desired product.
The solvent was removed under reduced pressure, water (50 mL) was
added, and the product was extracted to DCM (5 × 40 mL). The
combined extracts were dried with Na2SO4 and evaporated to dryness.
The residue was purified by column chromatography (silica gel, 5%
Hexa-tert-butyl 3,3′-[Pyridine-2,6-diylbis(methylene)]bis(oxy)-
bis(1,5,9-triazacyclododecane-1,5,9-tricarboxylate) (18). 2,6-Bis-
(tosyloxymethyl)pyridine24 (0.72 mmol, 0.32 g) was used. Compound
1
18 was obtained in 76% yield (0.59 g). H NMR (CDCl3, 50 °C): δ
7.56 (t, J ) 7.7 Hz, 1H), 7.26 (d, J ) 7.7 Hz, 2H), 4.60 (s, 4H), 3.84
(quint., J ) 5.8 Hz, 2H), 3.54 (dd, J ) 6.2, 14.9 Hz, 4H), 3.35 (m,
12H), 1.94 (m, 4H), 1.70 (m, 4H), 1.36 (s, 36H), 1.35 (18H). 13C NMR
(CDCl3, 50 °C): δ 157.76, 156.10, 155.84, 137.08, 119.84, 79.72, 79.45,
76.43, 72.59, 49.30, 46.96, 44.76, 29.39, 28.34, 28.31. HR-MS for
(C55H95N7O14 + H)+: requires 1078.7015, found 1078.6977.
1
MeOH in DCM). Yield: 7.7 g (83.2%). H NMR (CDCl3, 50 °C): δ
4.04 (quint., J ) 5.8 Hz, 1H), 3.44 (m, 12H), 1.85 (quint., J ) 6.7 Hz,
4H), 1.50 (s, 18H), 1.48 (s, 9H). 13C NMR (CDCl3, 50 °C): δ 155.77,
80.65, 79.55, 73.55, 53.56, 47.72, 43.43, 28.44, 28.36. HR-MS for
(C24H45N3O7 + H)+: requires 488.3336, found 488.3328.
Nona-tert-butyl 3,3′,3′′-[Benzene-1,3,5-triyltris(methylene)]tris-
(oxy)tris(1,5,9-triazacyclododecane-1,5,9-tricarboxylate) (19). 1,3,5-
Tris(bromomethyl)benzene25 (0.48 mmol, 0.17 g) was used. Compound
1
19 was obtained in 80% yield (0.56 g). H NMR (CDCl3, 50 °C): δ
7.07 (s, 3H), 4.49 (s, 6H), 3.77 (quint., J ) 5.9 Hz, 3H), 3.49 (dd,
J ) 6.1, 14.9 Hz, 6H), 3.32 (m, 18H), 3.07 (m, 12H), 1.92 (m, 6H),
1.68 (s, 6H), 1.35 (s, 54H), 1.34 (s, 27H). 13C NMR (CDCl3, 50 °C):
δ 156.05, 155.80, 138.78, 125.69, 79.61, 79.36, 75.79, 71.71, 49.62,
46.85, 44.82, 29.36, 28.34, 28.32. HR-MS for (MH - C5H8O2)+,
C81H141N9O21: requires 1476.9796, found 1476.9840.
General Procedure for Preparation of Ligands 1-6. Compounds
14-19 were dissolved in MeOH (30 mL). Concentrated aqueous HCl
(0.8 mL) was added. The mixture was incubated at 40-45 °C for 2 h.
Upon the solution cooling to 0 °C, the deprotected product precipitated
as a hydrochloride. The hydrochlorides were converted to free bases
by passing their aqueous solutions through a strong anion-exchange
resin (Dowex 1X2, OH- form).
General Procedure for Preparation of the Boc-Protected Ligands
(14-19). R,R′-Bis(halomethyl)arene (0.72 mmol, to obtain 1-4),
pyridine-2,6-diyl ditosylate (0.72 mmol, to obtain 5), or 1,3,5-tris-
(bromomethyl)benzene (0.48 mmol, to obtain 6) was dissolved in dry
DMF (20 mL), and tri-tert-butyl 1,5,9-triazacyclododecan-3-ol-1,5,9-
tricarboxylate (13) (1.44 mmol, 0.7 g) was added. Dry sodium hydride
(2.1 mmol, 50 mg) was added, and the mixture was stirred for 1 h at
room temperature. The unreacted sodium hydride was destroyed with
MeOH (2 mL), and the volatiles were removed under reduced pressure.
The residue was dissolved in water (40 mL) and extracted with DCM
(5 × 20 mL). The combined extracts were dried with Na2SO4 and
evaporated to dryness under reduced pressure. The product was purified
by column chromatography (silica gel, 25-40% ethyl acetate in DCM).
Hexa-tert-butyl 3,3′-[1,2-Phenylenebis(methylene)bis(oxy)]bis-
(1,5,9-triazacyclododecane-1,5,9-tricarboxylate) (14). 1,2-Bis(bro-
momethyl)benzene (0.72 mmol, 0.19 g) was used as a starting material.
1,2-Bis[(1,5,9-triazacyclododecan-3-yloxy)methyl]benzene Hexahy-
1
drochloride (1). Yield: 94%. H NMR (D2O): δ 7.42 (m, 2H), 7.34
(m, 2H), 4.73 (s, 4H), 4.04 (m, 2H), 3.23 (m, 24H), 2.03 (m, 8H). 13
C
1
NMR (D2O): δ 135.13, 129.38, 128.90, 70.26, 68.80, 47.06, 44.05,
41.63, 19.97. HR-MS for (C26H48N6O2 + H)+: requires 477.3917, found
477.3892.
Compound 14 was obtained in 76% yield (0.59 g). H NMR (CDCl3,
50 °C): δ 7.37 (m, 2H), 7.24 (m, 2H), 4.67 (s, 4H), 3.84 (quint., J )
4.9 Hz, 2H), 3.59 (dd, J ) 6.1, 14.8 Hz, 4H), 3.42 (m, 12H), 3.11 (m,
8H), 2.01 (m, 4H), 1.74 (m, 4H), 1.45 (s, 54H). 13C NMR (CDCl3, 50
°C): δ 156.22, 155.95, 136.42, 128.64, 127.59, 79.79, 79.54, 75.33,
69.13, 49.53, 47.02, 44.79, 29.43, 28.43, 28.40. HR-MS for (MH -
C5H8O2)+, C56H96N6O14: requires 977.6538, found 977.6503.
Hexa-tert-butyl 3,3′-[1,3-Phenylenebis(methylene)bis(oxy)]bis-
(1,5,9-triazacyclododecane-1,5,9-tricarboxylate) (15). 1,3-Bis(bro-
momethyl)benzene (0.72 mmol, 0.19 g) was used. Compound 15 was
obtained in 83% yield (0.64 g). 1H NMR (CDCl3, 50 °C): δ 7.24 (m,
1,3-Bis[(1,5,9-triazacyclododecan-3-yloxy)methyl]benzene Hexahy-
drochloride (2). Yield: 92%. 1H NMR (D2O, 50 °C): δ 7.68 (m, 4H),
4.93 (s, 4H), 4.31 (m, 2H), 3.68 (dd, J ) 5.4, 13.8 Hz, 4H), 3.51 (m,
16H), 3.35 (m, 4H), 2.33 (m, 8H). 13C NMR (D2O, 50 °C): δ 138.05,
129.77, 128.69, 128.45, 71.75, 71.37, 48.94, 45.41, 43.50, 21.52. HR-
MS for (C26H48N6O2 + H)+: requires 477.3917, found 477.3897.
1,4-Bis[(1,5,9-triazacyclododecan-3-yloxy)methyl]benzene Hexahy-
drochloride (3). Yield: 96%. 1H NMR (D2O, 50 °C): δ 7.70 (s, 4H),
9
J. AM. CHEM. SOC. VOL. 128, NO. 33, 2006 10727